Choussat R - Search Results

1

[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes].

Choussat R, Collet JP, Beygui F, Borentain M, Montalescot G. Choussat R, et al. Ann Cardiol Angeiol (Paris). 2003 Dec;52 Suppl 1:1s-9s. Ann Cardiol Angeiol (Paris). 2003. PMID: 14752916 Review. French.

2

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P; ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. Montalescot G, et al. Among authors: choussat r. N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503. N Engl J Med. 2001. PMID: 11419426 Free article. Clinical Trial.

3

[Review and future perspectives on low-molecular-weight heparin].

Collet JP, Choussat R, Montalescot G. Collet JP, et al. Among authors: choussat r. Arch Mal Coeur Vaiss. 2001 Nov;94(11 Suppl):1233-42. Arch Mal Coeur Vaiss. 2001. PMID: 11794964 Review. French.

4

[Non-ST acute coronary syndromes].

Collet JP, Choussat R, Montalescot G. Collet JP, et al. Among authors: choussat r. Arch Mal Coeur Vaiss. 2002 Nov;95 Spec No 7:37-42. Arch Mal Coeur Vaiss. 2002. PMID: 12500603 Review. French.

5

Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.

Collet JP, Montalescot G, Golmard JL, Tanguy ML, Ankri A, Choussat R, Beygui F, Drobinski G, Vignolles N, Thomas D. Collet JP, et al. Among authors: choussat r. Am Heart J. 2004 Apr;147(4):655-61. doi: 10.1016/j.ahj.2003.10.019. Am Heart J. 2004. PMID: 15077081

6

Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.

Montalescot G, Collet JP, Tanguy ML, Ankri A, Payot L, Dumaine R, Choussat R, Beygui F, Gallois V, Thomas D. Montalescot G, et al. Among authors: choussat r. Circulation. 2004 Jul 27;110(4):392-8. doi: 10.1161/01.CIR.0000136830.65073.C7. Epub 2004 Jul 12. Circulation. 2004. PMID: 15249498 Clinical Trial.

7

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes.

Collet JP, Montalescot G, Blanchet B, Tanguy ML, Golmard JL, Choussat R, Beygui F, Payot L, Vignolles N, Metzger JP, Thomas D. Collet JP, et al. Among authors: choussat r. Circulation. 2004 Oct 19;110(16):2361-7. doi: 10.1161/01.CIR.0000145171.89690.B4. Epub 2004 Oct 11. Circulation. 2004. PMID: 15477397

8

[Antithrombotics in pre-hospital phase of acute coronary syndromes].

Collet JP, Dumaine R, Ecollan P, Beygui F, Choussat R, Boon G, Payot L, Montalescot G. Collet JP, et al. Among authors: choussat r. Arch Mal Coeur Vaiss. 2005 Nov;98(11):1118-22. Arch Mal Coeur Vaiss. 2005. PMID: 16379108 Review. French.

9

Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.

Le Feuvre C, Batisse A, Collet JP, Batisse JP, Choussat R, Beygui F, Helft G, Montalescot G, Metzger JP. Le Feuvre C, et al. Among authors: choussat r. Catheter Cardiovasc Interv. 2006 Jun;67(6):852-8. doi: 10.1002/ccd.20670. Catheter Cardiovasc Interv. 2006. PMID: 16649230 Clinical Trial.

10

Fibrinogen as a risk factor for coronary heart disease.

Montalescot G, Collet JP, Choussat R, Thomas D. Montalescot G, et al. Among authors: choussat r. Eur Heart J. 1998 Jul;19 Suppl H:H11-7. Eur Heart J. 1998. PMID: 9717059 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page